9443638

Source:http://linkedlifedata.com/resource/pubmed/id/9443638

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022341, umls-concept:C0045093, umls-concept:C0282460, umls-concept:C0441655, umls-concept:C0684249, umls-concept:C1257890, umls-concept:C1274040
pubmed:issue	3
pubmed:dateCreated	1998-2-10
pubmed:abstractText	This phase II study was conducted to determine the response and toxicity of gemcitabine (2',2'-difluorodeoxycytidine) in chemotherapy-naive patients with non-small-cell lung cancer (NSCLC).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:issn	0344-5704
pubmed:author	pubmed-author:FukuokaMM, pubmed-author:FuruseKK, pubmed-author:KameiTT, pubmed-author:KudoSS, pubmed-author:NegoroSS, pubmed-author:NiitaniHH, pubmed-author:NishikawaHH, pubmed-author:TakadaMM, pubmed-author:TakadaYY
pubmed:issnType	Print
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	217-22
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9443638-Adult, pubmed-meshheading:9443638-Aged, pubmed-meshheading:9443638-Antimetabolites, Antineoplastic, pubmed-meshheading:9443638-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:9443638-Deoxycytidine, pubmed-meshheading:9443638-Drug Administration Schedule, pubmed-meshheading:9443638-Female, pubmed-meshheading:9443638-Humans, pubmed-meshheading:9443638-Japan, pubmed-meshheading:9443638-Lung Neoplasms, pubmed-meshheading:9443638-Male, pubmed-meshheading:9443638-Middle Aged, pubmed-meshheading:9443638-Survival Analysis
pubmed:year	1998
pubmed:articleTitle	Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study.
pubmed:affiliation	Pulmonary Medicine, Rinku General Medical Center, Izumisano-city, Osaka, Japan.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II